Associated Papers
GNAQ/GNA11-Related Benign and Malignant Entities-A Common Histoembriologic Origin or a Tissue-Dependent Coincidence.
Pilch J et al.
Cancers, 2024
Somatic GNA11/GNAQ variants in a cohort of Chinese children with phakomatosis pigmentovascularis.
Zhang B et al.
Pediatric Investigation, 2024
Pathogenic postzygotic mosaicism in the tyrosine receptor kinase pathway: potential unidentified human disease hidden away in a few cells.
Tiemann-Boege I et al.
The Febs Journal, 2021
Identification of a Mosaic Activating Mutation in GNA11 in Atypical Sturge-Weber Syndrome.
Thorpe J et al.
The Journal of Investigative Dermatology, 2021
GNA11 Mutation as a Cause of Sturge-Weber Syndrome: Expansion of the Phenotypic Spectrum of Gα/11 Mosaicism and the Associated Clinical Diagnoses.
Polubothu S et al.
The Journal of Investigative Dermatology, 2020
Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal Melanoma.
Piaggio F et al.
Cancers, 2019
Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review.
Kumar A et al.
American Journal of Medical Genetics. Part A, 2019
Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.
Thomas AC et al.
The Journal of Investigative Dermatology, 2016
Select a paper to view details